Ergoteles LLC Novo Cure LTD Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $1.14 Million - $1.5 Million	16,798 New	16,798 $1.28 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $2.74 Million - $4.58 Million	-23,548 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$130.4 - $225.58 $3.07 Million - $5.31 Million	23,548 New	23,548 $5.22 Million
Q1 2021 May 12, 2021	SELL	$124.11 - $190.17 $3.77 Million - $5.78 Million	-30,400 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$112.16 - $174.14 $2.3 Million - $3.57 Million	20,475 Added 206.3%	30,400 $5.26 Million
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $576,146 - $1.1 Million	9,925 New	9,925 $1.11 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.